IBD & Intestinal Disorders
Latest News
Large cohort study finds isotretinoin not associated with IBD
The study also evaluated the association of inflammatory bowel disease with oral tetracyclines and with acne itself.
Conference Coverage
Herbal combination tames active UC in small study
Derivatives of an intensely yellow spice and an intensely blue dye combined to resolve active ulcerative colitis in a small randomized trial.
Conference Coverage
Adult stem cells can heal intractable perianal Crohn’s fistulae
Many patients experienced complete healing within 3 months of a single infusion of mesenchymal stem cells.
Latest News
First Humira biosimilar launches in U.S.
Amgen’s Amjevita will be offered at 5% and 55% below Humira’s list price, but patients may not benefit from the more significant discount.
Conference Coverage
Gut enzymes fingered in some 5-ASA treatment failures
Patients with inflammatory bowel disease who had three or four specific acetyltransferases in their gut microbiota had a threefold higher risk for...
Conference Coverage
Food additives may exacerbate IBD
Emulsifiers and thickeners added to food in processing may contribute to inflammation and changes in gut microbiota.
Conference Coverage
Proof lacking for dual-targeted therapy benefit in IBD
Questions remain unanswered about the effectiveness of combination biologic treatment for inflammatory bowel disease.
From the Journals
Updated celiac disease guideline addresses common clinical questions
The “discussion on the lack of evidence behind gluten-detection devices and probiotic use in celiac disease addresses conversations that come up...
From the Journals
Two novel JAK inhibitors show promise in ulcerative colitis
“As JAK inhibitors are associated with increased risk of major cardiovascular events and venous thromboembolisms, larger studies are needed for...
From the Journals
Two drug classes appear effective for gastroparesis treatment
“There are very few licensed therapies, but some novel drugs are in the pipeline, some existing drugs that are licensed for other conditions could...